Fig. 3

The mutation status of FGFR4 is closely associated with the prognosis of NSCLC. a The prevalence of FGFR4 mutations in NSCLC patients based on the cBioPortal for Cancer Genomics; b the expression of FGFR4 was closely related to the prognosis of lung cancer patients; c the mutation status of FGFR4 is associated with the TMB level in TCGA cohort; d the mutation status of FGFR4 is associated with the TMB level in cBioPortal for Cancer Genomics; e the mutation status of FGFR4 is associated with the PD-L1 expression in cBioPortal for Cancer Genomics; f the mutation status of FGFR4 is associated with the PFS of ICIs treatment in cBioPortal for Cancer Genomics